Manufacturer or GPO Program year 2022 Source: CMS Open Payments

TOLMAR Pharmaceuticals, Inc.

CO, United States

CMS manufacturer 100000071373

Open in the dashboard

General payments

$1,048,631

17,564 payments

Research payments

$0

0 payments

Ownership & investment interest

$0

None reported

Through program year 2022, TOLMAR Pharmaceuticals, Inc. reported paying $1,048,631 in general payments and $0 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2022 General $405,505 7,261
2021 General $272,039 4,881
2020 General $198,198 2,022
2019 General $172,888 3,400

Breakdown

Top recipients General payments · program year 2022
  1. Scott Sellinger Urology · Tallahassee, FL $29,396 18 payments
  2. Philippe Backeljauw Pediatric Endocrinology · Cincinnati, OH $23,353 11 payments
  3. Mayo Clinic Florida Teaching hospital · FL $17,500 1 payment
  4. Jeffrey Frankel Burien, WA $17,407 10 payments
  5. Childrens Hospital Colorado Teaching hospital · CO $15,750 1 payment
  6. Elward Crawford Urology · San Diego, CA $13,571 7 payments
  7. Lawrence Silverman Pediatric Endocrinology · Morristown, NJ $11,125 15 payments
  8. Anne Calvaresi Nurse Practitioner, Family · Philadelphia, PA $11,095 22 payments
  9. Jason Hafron Urology · West Bloomfield, MI $10,030 6 payments
  10. Marcela Vargas Trujillo Pediatric Endocrinology · San Diego, CA $9,507 7 payments
Products the payments named General payments · program year 2022
  1. Eligard Prostate Cancer $279,831 69% · 2,925 recipients
  2. Fensolvi Central Precocious Puberty (CPP) $122,229 30% · 432 recipients
  3. Alkindi Replacement therapy for pediatric patients with AI (ALKINDI SPRINKLE PI) $2,050 <1% · 92 recipients
  4. Jatenzo Endogenous Testosterone Replacement Therapy $1,560 <1% · 82 recipients
  5. Alkindi Replacement therapy for pediatric patients with AI (ALKINDI PI) $908 <1% · 45 recipients

Each share is of this company’s general payments naming a product in 2022. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2022
  1. Urology $134,425 38% · 1,561 practitioners
  2. Pediatric Endocrinology Pediatrics $106,229 30% · 269 practitioners
  3. Physician Assistant $31,541 9% · 349 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $22,675 6% · 301 practitioners
  5. Nurse Practitioner $12,185 3% · 190 practitioners

The top 5 of 67 specialties; each share is of this company’s general payments to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Florida $82,204 20% · 492 recipients
  2. California $43,288 11% · 272 recipients
  3. Ohio $28,181 7% · 141 recipients
  4. Pennsylvania $26,642 7% · 122 recipients
  5. Colorado $25,512 6% · 37 recipients

The top 5 of 50 states; each share is of this company’s general payments in 2022 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2022
  1. Honoraria $414,566 139 payments
  2. Food and Beverage $317,764 15,949 payments
  3. Consulting Fee $175,290 98 payments
  4. Travel and Lodging $84,395 153 payments
  5. Education $53,849 1,224 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,765 1 payment
Companies with a similar name General payments · program years 2019–2022
  1. Tolmar, Inc. CO, United States $1,298,781

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

17,564 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record